News about Global Pharma

Everest Medicines to Invest USD 30.9 Million in I-MAB

Everest Medicines has announced a strategic equity investment of USD 30.9 million in US-based biotech firm I-Mab, strengthening its position in next-generation oncology and enhancing synergies across global markets.

Global Pharma | 04/08/2025 | By Mrinmoy Dey |  158

Alveolus Bio Secures Strategic Investment from Shilpa Medicare

Alveolus Bio has announced a strategic financing round led by Shilpa Medicare, which will also serve as its exclusive global development and manufacturing partner to accelerate clinical advancement of its inhaled biotherapeutics for respiratory diseases.

Global Pharma | 04/08/2025 | By Mrinmoy Dey |  165

Moderna Sees 41 Percent Q2 Revenue Drop as COVID Vaccine Sales Decline

Moderna posted USD 142 million in revenue for the second quarter 2025, down 41 percent from USD 241 million in the same period last year.

Global Pharma | 04/08/2025 | By Dineshwori |  265

Aurobindo Pharma USA To Acquire Lannett For USD 250 Million, Enter ADHD Treatment Space

Aurobindo Pharma USA Inc., has entered into a definitive agreement to acquire 100 percent membership interest in Lannett Company LLC from its parent company, Lannett Seller Holdco, Inc.

Global Pharma | 31/07/2025 | By Dineshwori |  519

ESTEVE Acquires Regis Technologies to Strengthen US Footprint

This acquisition enables ESTEVE to expand its contract development and manufacturing services for small-molecule active pharmaceutical ingredients from pre-clinical to commercial manufacturing in the US.

Global Pharma | 31/07/2025 | By Mrinmoy Dey |  209

Celltrion to Acquire US Biologics Plant to Counter Potential Pharma Tariffs

Celltrion has been selected as the preferred bidder to acquire a large biologics manufacturing plant in the United States —a strategic move aimed at insulating the company from potential US pharmaceutical tariffs.

Global Pharma | 30/07/2025 | By Dineshwori |  569

Sandoz to Acquire Just-Evotec Biologics in USD 300 Million Deal

Sandoz has signed a non-binding term sheet with Evotec SE, paving the way for the potential acquisition of Just–Evotec Biologics EU SAS for approximately USD 300 million.

Global Pharma | 30/07/2025 | By Dineshwori |  348

Cellipont Bioservices and CellVax Therapeutics Expand Partnership for cGMP Manufacturing of FK-GI101

Cellipont Bioservices and CellVax Therapeutics have expanded their partnership to advance cGMP manufacturing and clinical development of FK-GI101, a personalised immunotherapy targeting gastrointestinal cancers, building on prior collaboration for prostate cancer therapy FK-PC101.

Global Pharma | 30/07/2025 | By Mrinmoy Dey |  197

Agilent Technologies Unveils New Biopharma Experience Center in Hyderabad

Agilent Technologies has launched a new Biopharma Experience Center in Hyderabad, Telangana, as part of its broader three-to-five-year India growth strategy.

Global Pharma | 30/07/2025 | By Dineshwori |  300

Zydus Acquires 85.6 Percent Stake in Amplitude Surgical for EUR 256 Million

Zydus Lifesciences Ltd. has completed the EUR 256 million acquisition of an 85.6 percent stake in France-based Amplitude Surgical, marking a strategic move to strengthen its global presence in the orthopaedics space.

Global Pharma | 30/07/2025 | By Mrinmoy Dey |  180